{"nct_id":"NCT04006704","title":"Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo Tablets","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2019-10-10","start_date_type":"ACTUAL","primary_completion_date":"2020-03-06","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}